As a contract research organization (CRO), Scantox supports a wide range of drug development activities, from lead compound optimization through in vitro and in vivo efficacy study models, formulation development, regulatory toxicity studies, to drug manufacturing for Phase I and II clinical trials. With our trusted collaboration based on our advanced technical capabilities and over 40 years of scientific experience, we are able to provide a one-stop service for your development projects.

In particular, they are one of the world's leading CROs in the field of pharmaceutical safety studies using mini-pigs, and they also have extensive experience in efficacy studies and genotoxicity testing in the fields of neurological disorders and rare diseases.